Importantly, our results suggest that CYP27A1 transcript expression may perform better than protein expression as a biomarker for prognostication purposes, for all endpoints evaluated in this study (similarly high CYP27A1 expression was also associated with a better breast cancer specific survival among all patients and subgroups; data not shown). The gene discussed is CYP27A1; the disease is breast cancer.